NASDAQ:CLPT

Clearpoint Neuro Stock Insider Trading

Healthcare > Medical - Devices

Buy CLPT

*Your capital is at risk

$14.94

+0.360 (+2.47%)

At Close: Jul 31, 2026

ClearPoint Neuro Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -37.67. In total, the insiders bought 1.39M and sold 291.32K CLPT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-37.67
● Buy	1.39M shares
● Sell	291.32K shares
77% Buy Activity Negligible or No Correlation
Sell Signal Medium Confidence Jun 17, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -37.67. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 19, 2026 Buy	Common Stock M-Exempt	Liau Linda M. Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Restricted Stock Units M-Exempt	Girin Pascal E R Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Common Stock M-Exempt	Girin Pascal E R Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Restricted Stock Units M-Exempt	Johnson B Kristine Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Common Stock M-Exempt	Johnson B Kristine Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Restricted Stock Units M-Exempt	Fallon Lynnette C Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Common Stock M-Exempt	Fallon Lynnette C Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Restricted Stock Units M-Exempt	Klein Matthew B. Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Common Stock M-Exempt	Klein Matthew B. Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Common Stock M-Exempt	Fletcher R John Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Restricted Stock Units M-Exempt	Fletcher R John Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Common Stock M-Exempt	Richards Timothy T. Director	Director	12 417 Value: $138.7K
May 19, 2026 Buy	Restricted Stock Units M-Exempt	Richards Timothy T. Director	Director	12 417 Value: $138.7K
Apr 01, 2026 Buy	Common Stock A-Award	Richards Timothy T. Director	Director	442 Value: $4K
Apr 01, 2026 Buy	Common Stock A-Award	Fletcher R John Director	Director	1 270 Value: $11.6K
Apr 01, 2026 Buy	Common Stock A-Award	Girin Pascal E R Director	Director	755 Value: $7K
Mar 19, 2026 Buy	Stock Options (right to buy) M-Exempt	Burnett Joseph CEO And President	CEO / President	20 942 Value: $67.9K
Mar 19, 2026 Buy	Common Stock M-Exempt	Burnett Joseph CEO And President	CEO / President	20 942 Value: $67.9K
Mar 12, 2026 Sell	Common Stock F-InKind	Burnett Joseph CEO And President	CEO / President	43 161 Value: $497.6K
Mar 12, 2026 Buy	Common Stock M-Exempt	Burnett Joseph CEO And President	CEO / President	84 829 Value: $978.1K
Mar 12, 2026 Buy	Restricted Stock Units M-Exempt	D'alessandro Danilo Chief Financial Officer	C-Suite Officer	32 627 Value: $376.2K
Mar 12, 2026 Sell	Common Stock F-InKind	D'alessandro Danilo Chief Financial Officer	C-Suite Officer	16 601 Value: $191.4K
Mar 12, 2026 Buy	Common Stock M-Exempt	D'alessandro Danilo Chief Financial Officer	C-Suite Officer	32 627 Value: $376.2K
Mar 12, 2026 Buy	Restricted Stock Units M-Exempt	Burnett Joseph CEO And President	CEO / President	84 829 Value: $978.1K
Mar 12, 2026 Buy	Common Stock M-Exempt	Stigall L. Jeremy Chief Business Officer	Officer	30 995 Value: $357.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CLEARPOINT NEURO, INC.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into...

Read Full Profile Here